JYNT vs XPOF

For growth investors, The Joint Corp.

(JYNT) is the stronger pick with 5. 2% revenue growth year-over-year, versus -1. 7% for Xponential Fitness, Inc. (XPOF). The Joint Corp. (JYNT) offers the better valuation at 46. 3x trailing P/E (45. 5x forward), making it the more compelling value choice. Analysts rate The Joint Corp. (JYNT) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On forward P/E, Xponential Fitness, Inc.

is actually cheaper at 11. 0x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Xponential Fitness, Inc.

(XPOF) delivered a total return of -45. 9%, compared to -82. 7% for The Joint Corp. (JYNT). Over 10 years, the gap is even starker: JYNT returned +183. 9% versus XPOF's -45. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), The Joint Corp.

(JYNT) is the lower-risk stock at 0. 98β versus Xponential Fitness, Inc. 's 1. 94β — meaning XPOF is approximately 97% more volatile than JYNT relative to the S&P 500.

By revenue growth (latest reported year), The Joint Corp.

(JYNT) is pulling ahead at 5. 2% versus -1. 7% for Xponential Fitness, Inc. (XPOF). On earnings-per-share growth, the picture is similar: The Joint Corp. grew EPS 133. 9% year-over-year, compared to 35. 2% for Xponential Fitness, Inc.. Over a 3-year CAGR, XPOF leads at 9. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

The Joint Corp.

(JYNT) is the more profitable company, earning 5. 3% net margin versus -10. 7% for Xponential Fitness, Inc. — meaning it keeps 5. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: XPOF leads at 25. 3% versus -1. 6% for JYNT. At the gross margin level — before operating expenses — JYNT leads at 76. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Xponential Fitness, Inc.

(XPOF) trades at 11. 0x forward P/E versus 45. 5x for The Joint Corp. — 34. 5x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for JYNT: 127. 3% to $20. 00.

In this comparison, XPOF (2.

5% yield) pays a dividend. JYNT does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, The Joint Corp.

(JYNT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 98), +183. 9% 10Y return). Xponential Fitness, Inc. (XPOF) carries a higher beta of 1. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (JYNT: +183. 9%, XPOF: -45. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (JYNT (Healthcare) and XPOF (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

XPOF pays a dividend while JYNT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.